First Time Loading...
J

Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015

Watchlist Manager
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
Watchlist
Price: 133 SAR -1.63% Market Closed
Updated: May 15, 2024

Wall Street
Price Targets

Price Targets Summary
Jamjoom Pharmaceuticals Factory Company SJSC

Wall Street analysts forecast Jamjoom Pharmaceuticals Factory Company SJSC stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Jamjoom Pharmaceuticals Factory Company SJSC is 124.87 SAR with a low forecast of 102.87 SAR and a high forecast of 150.15 SAR.

Lowest
Price Target
102.87 SAR
23% Downside
Average
Price Target
124.87 SAR
6% Downside
Highest
Price Target
150.15 SAR
13% Upside
Jamjoom Pharmaceuticals Factory Company SJSC Competitors:
Price Targets
VIRP
Virbac SA
4% Upside
600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
2% Downside
600566
Hubei Jumpcan Pharmaceutical Co Ltd
32% Upside
4519
Chugai Pharmaceutical Co Ltd
31% Upside
ORCHPHARMA
Orchid Pharma Ltd
17% Upside
BSEM
Biostem Technologies Inc
145% Upside
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
35% Downside
TBPH
Theravance Biopharma Inc
60% Upside

Revenue
Forecast

Revenue Estimate
Jamjoom Pharmaceuticals Factory Company SJSC

For the last 2 years the compound annual growth rate for Jamjoom Pharmaceuticals Factory Company SJSC's revenue is 22%. The projected CAGR for the next 2 years is 18%.

22%
Past Growth
18%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Jamjoom Pharmaceuticals Factory Company SJSC

For the last 2 years the compound annual growth rate for Jamjoom Pharmaceuticals Factory Company SJSC's operating income is 30%. The projected CAGR for the next 2 years is 18%.

30%
Past Growth
18%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Jamjoom Pharmaceuticals Factory Company SJSC

For the last 2 years the compound annual growth rate for Jamjoom Pharmaceuticals Factory Company SJSC's net income is 31%. The projected CAGR for the next 2 years is 17%.

31%
Past Growth
17%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Jamjoom Pharmaceuticals Factory Company SJSC's stock price target?
Price Target
124.87 SAR

According to Wall Street analysts, the average 1-year price target for Jamjoom Pharmaceuticals Factory Company SJSC is 124.87 SAR with a low forecast of 102.87 SAR and a high forecast of 150.15 SAR.

What is Jamjoom Pharmaceuticals Factory Company SJSC's Revenue forecast?
Projected CAGR
18%

For the last 2 years the compound annual growth rate for Jamjoom Pharmaceuticals Factory Company SJSC's revenue is 22%. The projected CAGR for the next 2 years is 18%.

What is Jamjoom Pharmaceuticals Factory Company SJSC's Operating Income forecast?
Projected CAGR
18%

For the last 2 years the compound annual growth rate for Jamjoom Pharmaceuticals Factory Company SJSC's operating income is 30%. The projected CAGR for the next 2 years is 18%.

What is Jamjoom Pharmaceuticals Factory Company SJSC's Net Income forecast?
Projected CAGR
17%

For the last 2 years the compound annual growth rate for Jamjoom Pharmaceuticals Factory Company SJSC's net income is 31%. The projected CAGR for the next 2 years is 17%.